Skip to main content
. 2023 Apr 5;15(4):1148. doi: 10.3390/pharmaceutics15041148

Figure 2.

Figure 2

Cytotoxicity (MTT) (72 h) in 5 lung cancer cell lines incubated with various concentrations of KAN0441571C, erlotinib, or ibrutinib.